https://www.marketscreener.com/quote/stock/INNATE-PHARMA-35620/news/Innate-Pharma-RECEIVES-PRIME-DESIGNATION-FROM-THE-EUROPEAN-MEDICINES-AGENCY-FOR-LACUTAMAB-IN-SEZA-31771804/?utm_source=telegram&utm_medium=social&utm_campaign=share